# Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence

> **NCT06250010** · — · RECRUITING · sponsor: **Regina Elena Cancer Institute** · enrollment: 30 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DIAGNOSTIC_TEST:** tissue samples (healthy and tumor taken from the same patient) and tissue samples (decidualized endometrium and trophoblast taken from it patient)

## Key facts

- **NCT ID:** NCT06250010
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-13
- **Primary completion:** 2025-12-13
- **Final completion:** 2025-12-13
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06250010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06250010, "Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06250010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*